FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283266362> ?p ?o ?g. }

• W4283266362 abstract "Background: Stimulant use has substantially increased among people with opioid use disorder (OUD) and is associated with worse treatment outcomes. This study’s objective was to compare risk of stimulant-related emergency department (ED) and hospital admissions associated with exposure to bupropion, OUD medication (buprenorphine, naltrexone, and methadone), and selective serotonin reuptake inhibitors (SSRIs; active comparator) relative to days without active prescriptions for medication. Methods: This recurrent-event, case-crossover study used insurance claims from 51,084 individuals with OUD enrolled in the IBM MarketScan (2006–2016) Databases who had at least 1 stimulant-related ED or hospital admission. Conditional logistic regression models estimated the risk of admissions between days without active prescriptions and days with prescriptions for bupropion, OUD medication, and SSRIs. Secondary analyses were conducted by stimulant subtype (cocaine; amphetamine) and event subtype (falls, injuries, or poisonings; psychotic events). Results: Compared to days without active prescriptions, days with bupropion treatment were associated with decreased odds of stimulant-related ED or hospital admissions (odds ratio = 0.77; 95% confidence interval , 0.72–0.82) Among OUD medications, we observed strong protective associations with decreased admissions for buprenorphine (OR = 0.67; 95% CI, 0.64–0.71), naltrexone (OR = 0.65; 95% CI, 0.60–0.70), and methadone (OR = 0.59; 95% CI, 0.51–0.67). The SSRI active comparator group was associated with a small protective association with decreased admissions (OR = 0.90; 95% CI, 0.86–0.93). These effects were sustained in secondary analyses stratifying by stimulant and event subtype. Conclusions: Bupropion and OUD medication, including both naltrexone and opioid agonists, are associated with fewer stimulant-related ED or hospital admissions in patients with OUD. Bupropion may show promise as adjunctive therapy targeting stimulant-specific poisoning risk." @default.
• W4283266362 created "2022-06-23" @default.
• W4283266362 creator A5012603116 @default.
• W4283266362 creator A5018412114 @default.
• W4283266362 creator A5052057488 @default.
• W4283266362 creator A5061322391 @default.
• W4283266362 creator A5077159635 @default.
• W4283266362 date "2022-06-20" @default.
• W4283266362 modified "2023-10-14" @default.
• W4283266362 title "Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder" @default.
• W4283266362 cites W1984324957 @default.
• W4283266362 cites W2011633221 @default.
• W4283266362 cites W2012172390 @default.
• W4283266362 cites W2068311250 @default.
• W4283266362 cites W2089003623 @default.
• W4283266362 cites W2117930349 @default.
• W4283266362 cites W2121153184 @default.
• W4283266362 cites W2167284547 @default.
• W4283266362 cites W2286805151 @default.
• W4283266362 cites W2293959932 @default.
• W4283266362 cites W2411724849 @default.
• W4283266362 cites W2473446924 @default.
• W4283266362 cites W2586087098 @default.
• W4283266362 cites W2587097985 @default.
• W4283266362 cites W2622394398 @default.
• W4283266362 cites W2624396785 @default.
• W4283266362 cites W2740332189 @default.
• W4283266362 cites W2768214444 @default.
• W4283266362 cites W2897850254 @default.
• W4283266362 cites W2943532942 @default.
• W4283266362 cites W2947319912 @default.
• W4283266362 cites W2990459606 @default.
• W4283266362 cites W2995842198 @default.
• W4283266362 cites W3010839704 @default.
• W4283266362 cites W3020904116 @default.
• W4283266362 cites W3027676659 @default.
• W4283266362 cites W3081443442 @default.
• W4283266362 cites W3088270938 @default.
• W4283266362 cites W3088335326 @default.
• W4283266362 cites W3118735640 @default.
• W4283266362 cites W3121457630 @default.
• W4283266362 cites W3130493692 @default.
• W4283266362 cites W3133562656 @default.
• W4283266362 cites W4238622864 @default.
• W4283266362 doi "https://doi.org/10.4088/jcp.21m14112" @default.
• W4283266362 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35759785" @default.
• W4283266362 hasPublicationYear "2022" @default.
• W4283266362 type Work @default.
• W4283266362 citedByCount "2" @default.
• W4283266362 countsByYear W42832663622023 @default.
• W4283266362 crossrefType "journal-article" @default.
• W4283266362 hasAuthorship W4283266362A5012603116 @default.
• W4283266362 hasAuthorship W4283266362A5018412114 @default.
• W4283266362 hasAuthorship W4283266362A5052057488 @default.
• W4283266362 hasAuthorship W4283266362A5061322391 @default.
• W4283266362 hasAuthorship W4283266362A5077159635 @default.
• W4283266362 hasBestOaLocation W42832663622 @default.
• W4283266362 hasConcept C118552586 @default.
• W4283266362 hasConcept C126322002 @default.
• W4283266362 hasConcept C142724271 @default.
• W4283266362 hasConcept C156957248 @default.
• W4283266362 hasConcept C170493617 @default.
• W4283266362 hasConcept C2426938 @default.
• W4283266362 hasConcept C2777843972 @default.
• W4283266362 hasConcept C2777972943 @default.
• W4283266362 hasConcept C2778767360 @default.
• W4283266362 hasConcept C2778949969 @default.
• W4283266362 hasConcept C2779418921 @default.
• W4283266362 hasConcept C2779908668 @default.
• W4283266362 hasConcept C2780557958 @default.
• W4283266362 hasConcept C2781063702 @default.
• W4283266362 hasConcept C42219234 @default.
• W4283266362 hasConcept C44249647 @default.
• W4283266362 hasConcept C71924100 @default.
• W4283266362 hasConcept C98274493 @default.
• W4283266362 hasConceptScore W4283266362C118552586 @default.
• W4283266362 hasConceptScore W4283266362C126322002 @default.
• W4283266362 hasConceptScore W4283266362C142724271 @default.
• W4283266362 hasConceptScore W4283266362C156957248 @default.
• W4283266362 hasConceptScore W4283266362C170493617 @default.
• W4283266362 hasConceptScore W4283266362C2426938 @default.
• W4283266362 hasConceptScore W4283266362C2777843972 @default.
• W4283266362 hasConceptScore W4283266362C2777972943 @default.
• W4283266362 hasConceptScore W4283266362C2778767360 @default.
• W4283266362 hasConceptScore W4283266362C2778949969 @default.
• W4283266362 hasConceptScore W4283266362C2779418921 @default.
• W4283266362 hasConceptScore W4283266362C2779908668 @default.
• W4283266362 hasConceptScore W4283266362C2780557958 @default.
• W4283266362 hasConceptScore W4283266362C2781063702 @default.
• W4283266362 hasConceptScore W4283266362C42219234 @default.
• W4283266362 hasConceptScore W4283266362C44249647 @default.
• W4283266362 hasConceptScore W4283266362C71924100 @default.
• W4283266362 hasConceptScore W4283266362C98274493 @default.
• W4283266362 hasIssue "4" @default.
• W4283266362 hasLocation W42832663621 @default.
• W4283266362 hasLocation W42832663622 @default.
• W4283266362 hasLocation W42832663623 @default.
• W4283266362 hasOpenAccess W4283266362 @default.
• W4283266362 hasPrimaryLocation W42832663621 @default.
• W4283266362 hasRelatedWork W2317290477 @default.

• next